Zheng Quan Shi Bao·2025-09-16 04:21Group 1 - The A-share market showed a relatively sluggish performance on September 16, with the Sci-Tech Innovation 50 Index performing better, rising over 2% at one point [1][3][4] - Despite the overall market volatility, a significant number of individual stocks remained active, with many hitting the daily limit up, prompting related companies to issue risk warnings [1][6] - The Sci-Tech Innovation 50 Index saw a strong performance, with component stocks like Haiguang Information rising over 10%, reaching a market capitalization of over 580 billion [4] Group 2 - In the Hong Kong market, the Hang Seng Index opened slightly higher but turned negative during the session, with Fosun Pharma experiencing a dramatic rise of over 400% [2][13][15] - Fosun Pharma announced the approval of its "Metformin and Empagliflozin Tablets (I)" for market, which is indicated for improving blood sugar control in adult patients with type 2 diabetes [18][19]